Bi-Specific Antibodies Today and Tomorrow: What APPs Need to Know

SELF STUDY / ENDURING - ESTIMATED TIME TO COMPLETE ACTIVITY: 46 Minutes

Overview

This program provides an in-depth review of FDA-approved and emerging bispecific antibodies, highlighting their mechanisms, clinical indications, and efficacy in hematologic malignancies. Participants will explore strategies for managing therapy-related toxicities, patient monitoring, and outpatient delivery, while considering evolving trends that may shape future patient care.

Target Audience

This CME initiative was designed for oncologists, surgeons, radiation oncologists, NPs, PAs, pharmacists, nurses, and other healthcare professionals involved in the treatment of patients with cancer.

Learning Objectives

  1. Describe the currently FDA-approved bispecific antibodies, including their indications, mechanisms of action, and clinical relevance in practice.
  2. Identify the clinical considerations and management strategies associated with bispecific therapies, including potential toxicities and patient monitoring.
  3. Discuss emerging trends and future directions in bispecific antibody development and their potential impact on patient care.

 

Course summary
Available credit: 
  • 0.75 AMA PRA Category 1 Credit™

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). Horizon CME is accredited by the ACCME to provide continuing medical education for physicians.

    Horizon CME designates this Enduring activity for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Course opens: 
06/12/2026
Course expires: 
06/12/2027
Cost:
$0.00
Rating: 
0

Faculty

Danielle Roberts, PA-C

Associate Chief of Education for APPs,
Co-Director Hematology/Oncology APP Fellowship
Winship Cancer Institute at Emory University
Atlanta, GA

Danielle Roberts serves as the co-director for the APP Fellowship.  She graduated from Emory University’s Physician Assistant Program in 2007. Upon graduation Danielle worked in community oncology before joining the Winship Cancer Institute in 2011.  She has enjoyed working in many oncologic specialties including Community Oncology, Survivorship, GVHD, and in her current position in Malignant Hematology.  Danielle currently serves as the Associate Chief of Education for the Winship Cancer Institute and is Society Leader and adjunct faculty for the Emory University Physician Assistant Program.  She is currently enrolled in the WHEA Teaching Fellowship and was honored with the 2022 Physician Assistant of the Year by Emory PA program.

Disclosures:

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, Horizon CME (HCME) ensures that continuing education activities are balanced, independent, objective, and scientifically rigorous. 

All persons in a position to influence the content of an accredited continuing education activity provided by Horizon CME are required to disclose to HCME any relevant financial relationships with ineligible companies within the past 24 months. All reported relevant financial relationships have been mitigated by Horizon CME.

Danielle Roberts, PA-C  discloses no relevant financial relationships with any entity producing, marketing, re-selling, or distributing healthcare goods or services consumed by, or used on, patients during the past 24 months.

Available Credit

  • 0.75 AMA PRA Category 1 Credit™

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). Horizon CME is accredited by the ACCME to provide continuing medical education for physicians.

    Horizon CME designates this Enduring activity for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Price

Cost:
$0.00
Please login or register to take this course.

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:

  1. Read the CME/CE information and faculty disclosures.
  2. Participate in the online activity.
  3. Complete the post-test
  4. Submit the evaluation form

DISCLAIMER:

This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

Required Hardware/software

Access to the internet is required.

Supported Browsers:

Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above

Google Chrome 28.0+ for Windows, Mac OS, or Linux

Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux

Safari 6.0+ for Mac OSX 10.7 and above

 

Supported Phones & Tablets:

 Android 4.0.3 and above

iPhone/iPad with iOS 6.1 or above